In:
Chemistry & Biodiversity, Wiley, Vol. 9, No. 9 ( 2012-09), p. 1718-1727
Kurzfassung:
Organometallic Ru II compounds are among the most widely studied anticancer agents. Functionalizing metal centers with biomolecule‐derived ligands has been shown to be a promising strategy to improve the antiproliferative activity of metal‐based chemotherapeutics. Herein, the synthesis of a series of novel 3‐hydroxypyridin‐2‐one‐derived ligands and their M II ( η 6 ‐ p ‐cymene) half‐sandwich complexes (M=Ru, Os) is described. The compounds were characterized by 1D‐ and 2D‐NMR spectroscopy, and elemental analysis.
Materialart:
Online-Ressource
ISSN:
1612-1872
,
1612-1880
DOI:
10.1002/cbdv.201200005
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2012
ZDB Id:
2139001-0
SSG:
12
Permalink